Professor Arnold Hill:

With breast cancer during Covid, we managed to see the urgent patients throughout the pandemic. There certainly was a temporary reduction in March, April and May 2020 but after that it picked back up. The most significant thing that happened during Covid was that, correctly, we had to pause the national breast screening programme because of the risk profile of a well person coming in and their getting Covid. Therefore, the screening programme was paused. That definitely caused a delay in the pick up of breast cancers. The screening programme is in a catch-up phase to recover from that pause that happened during Covid. That is probably the most significant thing.